|
NL7210355A
(cg-RX-API-DMAC7.html)
|
1971-08-03 |
1973-02-06 |
|
|
|
GB1447456A
(en)
|
1973-06-20 |
1976-08-25 |
Teijin Ltd |
Process for preparing desmosterols
|
|
GB8607294D0
(en)
|
1985-04-17 |
1986-04-30 |
Ici America Inc |
Heterocyclic amide derivatives
|
|
DE3823318A1
(de)
|
1988-07-09 |
1990-02-22 |
Bayer Ag |
(hetero)aryloxynaphthaline mit ueber schwefel gebundenen substituenten
|
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
|
EP0495639A1
(en)
|
1991-01-16 |
1992-07-22 |
Schering Corporation |
Use of interleukin-10 in adoptive immunotherapy of cancer
|
|
TW263508B
(cg-RX-API-DMAC7.html)
|
1991-02-12 |
1995-11-21 |
Pfizer |
|
|
US5229109A
(en)
|
1992-04-14 |
1993-07-20 |
Board Of Regents, The University Of Texas System |
Low toxicity interleukin-2 analogues for use in immunotherapy
|
|
JP3414433B2
(ja)
|
1993-03-01 |
2003-06-09 |
日本化薬株式会社 |
電子写真用トナー
|
|
DE19523446A1
(de)
|
1995-06-28 |
1997-01-02 |
Bayer Ag |
Benzotriazole
|
|
WO1997003945A1
(en)
|
1995-07-14 |
1997-02-06 |
Smithkline Beecham Corporation |
Substituted-pent-4-ynoic acids
|
|
RU2170735C2
(ru)
|
1995-08-10 |
2001-07-20 |
Байер Аг |
Производные галогензамещенного бензимидазола и их кислотно-аддитивные соли, промежуточные соединения и фунгицидное средство
|
|
IL124969A
(en)
|
1995-12-28 |
2002-09-12 |
Fujisawa Pharmaceutical Co |
History of benzimidazole, processes for their preparation and pharmaceutical preparations containing them
|
|
EP0934307B1
(en)
|
1996-06-19 |
2011-04-27 |
Aventis Pharma Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
|
EP0915825B1
(en)
*
|
1996-06-21 |
2004-05-06 |
Allergan, Inc. |
Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
|
US6180643B1
(en)
|
1996-11-19 |
2001-01-30 |
Amgen Inc. |
Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
|
|
US6392010B1
(en)
|
1996-12-19 |
2002-05-21 |
Aventis Pharmaceuticals Inc. |
Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and αβ-unsaturated carboxylic acid and aldehyde compounds
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
JP4327915B2
(ja)
|
1998-03-30 |
2009-09-09 |
株式会社デ・ウエスタン・セラピテクス研究所 |
スルフォンアミド誘導体
|
|
DE69928414T2
(de)
|
1998-09-18 |
2006-08-03 |
Abbott Gmbh & Co. Kg |
4-aminopyrrolopyrimidine als kinaseinhibitoren
|
|
US6348032B1
(en)
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
|
US6534535B1
(en)
|
1999-08-12 |
2003-03-18 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
ATE343383T1
(de)
|
1999-08-13 |
2006-11-15 |
Biogen Idec Inc |
Hemmer der zelladhäsion
|
|
CA2386474A1
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonist
|
|
AU2001285018A1
(en)
|
2000-08-17 |
2002-02-25 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer
|
|
AU2002246510B2
(en)
|
2000-11-09 |
2007-09-20 |
Neopharm, Inc. |
SN-38 lipid complexes and methods of use
|
|
TWI239942B
(en)
|
2001-06-11 |
2005-09-21 |
Dainippon Pharmaceutical Co |
N-arylphenylacetamide derivative and pharmaceutical composition containing the same
|
|
IL159848A0
(en)
|
2001-08-03 |
2004-06-20 |
Schering Corp |
Novel gamma secretase inhibitors
|
|
AU2002327096B2
(en)
|
2001-08-17 |
2007-11-22 |
Sankyo Agro Company, Limited |
3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
|
|
CA2488682C
(en)
|
2002-06-10 |
2014-04-01 |
Vaccinex, Inc. |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
US6894061B2
(en)
|
2002-12-04 |
2005-05-17 |
Wyeth |
Substituted dihydrophenanthridinesulfonamides
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
MXPA05006742A
(es)
|
2002-12-20 |
2005-09-08 |
Warner Lambert Co |
Benzoxazinas y derivados de las mismas como inhibidores de fosfoinositido-3-quinasas.
|
|
JP4601038B2
(ja)
|
2003-03-26 |
2010-12-22 |
第一三共株式会社 |
インドリルマレイミド類
|
|
US20080199486A1
(en)
|
2003-05-12 |
2008-08-21 |
Yair Argon |
Grp94-based compositions and methods of use thereof
|
|
BRPI0414533A
(pt)
|
2003-09-18 |
2006-11-07 |
Conforma Therapeutics Corp |
composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
|
|
EP1677803A2
(en)
|
2003-09-26 |
2006-07-12 |
Forbes Medi-Tech Inc. |
Method of inhibiting the expression of a multi-drug resistance genes and inhibiting the production of proteins resulting from the expression of such genes thereby enhancing the effectiveness of chemotherapeutic agents to treat cancers
|
|
WO2005033288A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
WO2005033048A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Wnt pathway antagonists
|
|
SE0302760D0
(sv)
|
2003-10-20 |
2003-10-20 |
Biovitrum Ab |
New compounds
|
|
US7420059B2
(en)
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
DE602004008668T2
(de)
|
2003-12-09 |
2008-06-12 |
F. Hoffmann-La Roche Ag |
Benzoxazinderivate und deren verwendungen
|
|
ATE457313T1
(de)
|
2003-12-23 |
2010-02-15 |
Novartis Ag |
Bicyclische heterocyclische p-38-kinase- inhibitoren
|
|
WO2005084208A2
(en)
|
2004-02-27 |
2005-09-15 |
New York University |
A novel class of sterol ligands and their uses in regulation of cholesterol and gene expression
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
CA2571710A1
(en)
|
2004-06-24 |
2006-11-02 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
|
JP2008505080A
(ja)
|
2004-07-01 |
2008-02-21 |
ニューヨーク ユニバーシティー |
ＲＯＲγｔ機能の調節のための組成物および方法
|
|
FR2874011B1
(fr)
|
2004-08-03 |
2007-06-15 |
Sanofi Synthelabo |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
US7304073B2
(en)
|
2004-08-20 |
2007-12-04 |
Wyeth |
Method of treating myocardial ischemia-reperfusion injury using NF-kB inhibitors
|
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
US7652043B2
(en)
|
2004-09-29 |
2010-01-26 |
The Johns Hopkins University |
WNT pathway antagonists
|
|
ATE549398T1
(de)
|
2004-10-08 |
2012-03-15 |
Us Gov Health & Human Serv |
Adoptive immuntherapie mit erhöhter t-lymphozyten-lebensdauer
|
|
DK1814580T3
(en)
|
2004-11-24 |
2016-12-12 |
Hutchinson Fred Cancer Res |
Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens
|
|
AR051780A1
(es)
|
2004-11-29 |
2007-02-07 |
Japan Tobacco Inc |
Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
|
|
GB0514911D0
(en)
|
2005-07-20 |
2005-08-24 |
Univ Birmingham |
T cell memory assay
|
|
RU2008110908A
(ru)
|
2005-08-25 |
2009-09-27 |
Шеринг Корпорейшн (US) |
Производные имидазола в качестве функционально селективных агонистов альфа2с адренорецепторов
|
|
US8003624B2
(en)
|
2005-08-25 |
2011-08-23 |
Schering Corporation |
Functionally selective ALPHA2C adrenoreceptor agonists
|
|
SI1937669T1
(sl)
|
2005-09-01 |
2012-05-31 |
Janssen Pharmaceutica Nv |
Novi derivati benzopirana kot odpiralci kalijevega kanala
|
|
CN101263116B
(zh)
|
2005-09-15 |
2011-12-07 |
霍夫曼-拉罗奇有限公司 |
可用作肝肉碱棕榈酰转移酶抑制剂的新型杂双环衍生物
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
AU2007214594B2
(en)
|
2006-02-13 |
2010-11-11 |
F. Hoffmann-La Roche Ag |
Heterobicyclic sulfonamide derivatives for the treatment of diabetes
|
|
US7659280B2
(en)
|
2006-02-17 |
2010-02-09 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
|
|
EP1996232B1
(en)
|
2006-03-01 |
2016-04-06 |
Janssen Pharmaceutica N.V. |
CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
|
|
EP2005177B1
(en)
|
2006-04-06 |
2013-07-10 |
Janssen R&D Ireland |
A homogeneous time resolved fluorescence based test method
|
|
CA2651072A1
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
US20080305169A1
(en)
|
2006-05-26 |
2008-12-11 |
Japan Tobacco Inc. |
Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
|
|
AU2007255042A1
(en)
|
2006-06-01 |
2007-12-13 |
Wyeth |
1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
|
|
CA2655694C
(en)
|
2006-07-03 |
2014-12-16 |
Biovitrum Ab (Publ) |
1,4-substituted indoles useful for modulation of the 5-ht6 receptor
|
|
JP2009543559A
(ja)
|
2006-07-12 |
2009-12-10 |
オンコティーエックス インコーポレイテッド |
癌特異的転写複合体の標的化のための組成物および方法
|
|
TWI315304B
(en)
|
2006-08-31 |
2009-10-01 |
Univ Taipei Medical |
Indoline-sulfonamides compounds
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
WO2008045664A2
(en)
|
2006-10-06 |
2008-04-17 |
Kalypsys, Inc. |
Heterocyclic pde4 inhibitors as antiinflammatory agents
|
|
WO2008062740A1
(fr)
|
2006-11-20 |
2008-05-29 |
Japan Tobacco Inc. |
Composé azoté à anneaux fusionnés et son utilisation
|
|
US7799933B2
(en)
|
2006-12-21 |
2010-09-21 |
Hoffman-La Roche Inc. |
Sulfonamide derivatives
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
WO2008150827A1
(en)
|
2007-05-29 |
2008-12-11 |
Smithkline Beecham Corporation |
Naphthyridine, derivatives as p13 kinase inhibitors
|
|
JP2010529843A
(ja)
|
2007-06-03 |
2010-09-02 |
オンコティーエックス インコーポレイテッド |
バイオマーカーおよび薬物標的としての、転写因子複合体の構成要素のがん関連アイソフォーム
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
WO2009032667A1
(en)
|
2007-08-29 |
2009-03-12 |
Smithkline Beecham Corporation |
Thiazole and oxazole kinase inhibitors
|
|
WO2009035997A2
(en)
|
2007-09-14 |
2009-03-19 |
Cara Therapeutics, Inc. |
Benzo-fused heterocycles
|
|
EP2203746B1
(en)
|
2007-09-24 |
2013-03-06 |
Technion Research & Development Foundation Ltd. |
T cell subpopulations capable of treating cancer
|
|
US20090131523A1
(en)
|
2007-10-15 |
2009-05-21 |
Enzymotec Ltd. |
Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis
|
|
RU2364597C1
(ru)
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
US7960377B2
(en)
|
2008-03-28 |
2011-06-14 |
Cara Therapeutics, Inc. |
Substituted pyridoxazines
|
|
ATE552255T1
(de)
|
2008-06-05 |
2012-04-15 |
Glaxo Group Ltd |
4-aminoindazole
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
US8163743B2
(en)
|
2008-06-05 |
2012-04-24 |
GlaxoGroupLimited |
4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
|
|
MX2010013264A
(es)
|
2008-06-09 |
2011-02-25 |
Sanofi Aventis |
Sulfonamidas n-heterociclicas aneladas con grupo de cabeza de oxadiazolona, procesos para su preparacion y su uso como sustancias farmaceuticas.
|
|
EP2288605B1
(en)
|
2008-06-09 |
2014-06-25 |
Sanofi |
Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
|
EP2298731A4
(en)
|
2008-06-25 |
2011-09-21 |
Takeda Pharmaceutical |
AMIDE COMPOUND
|
|
AU2009270255B2
(en)
|
2008-07-09 |
2013-12-12 |
Nissan Chemical Corporation |
Process for production of isoxazoline-substituted benzoic acid amide compound
|
|
WO2010017827A1
(en)
|
2008-08-14 |
2010-02-18 |
European Molecular Biology Laboratory |
6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases
|
|
EP2321407A4
(en)
|
2008-09-11 |
2012-07-18 |
Univ Florida |
SYSTEM AND METHOD FOR THE PRODUCTION OF T-CELLS
|
|
BRPI0925343A2
(pt)
|
2008-10-02 |
2015-07-28 |
Taisho Pharmaceutical Co Ltd |
Composto, composição farmacêutica, e, droga profilática ou terapêutica
|
|
EP2181710A1
(en)
|
2008-10-28 |
2010-05-05 |
Phenex Pharmaceuticals AG |
Ligands for modulation of orphan receptor-gamma (NR1F3) activity
|
|
WO2010057101A2
(en)
|
2008-11-17 |
2010-05-20 |
Schering Corporation |
Compounds useful as hiv blockers
|
|
AU2009316786A1
(en)
|
2008-11-19 |
2010-05-27 |
Merck Sharp & Dohme Corp. |
Inhibitors of diacylglycerol acyltransferase
|
|
CN102272153B
(zh)
|
2008-11-24 |
2015-04-15 |
德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 |
高亲和力t细胞受体及其应用
|
|
MX2011006555A
(es)
|
2008-12-19 |
2011-08-03 |
Sirtris Pharmaceuticals Inc |
Compuestos de tiazolopiridina moduladores de sirtuina.
|
|
TW201030007A
(en)
|
2009-02-06 |
2010-08-16 |
Gruenenthal Gmbh |
Substituted spiro-amides as b1r modulators
|
|
JP5656880B2
(ja)
|
2009-03-09 |
2015-01-21 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
|
|
WO2010117425A1
(en)
|
2009-03-31 |
2010-10-14 |
Biogen Idec Ma Inc. |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
|
JO3025B1
(ar)
|
2009-04-30 |
2016-09-05 |
Glaxo Group Ltd |
الأندازولات المستبدلة بالأوكسازول كمثبطات كيناز pi3
|
|
SG178125A1
(en)
|
2009-08-03 |
2012-03-29 |
Univ Miami |
Method for in vivo expansion of t regulatory cells
|
|
WO2011019634A2
(en)
|
2009-08-10 |
2011-02-17 |
Taipei Medical University |
Aryl substituted sulfonamide compounds and their use as anticancer agents
|
|
US8383099B2
(en)
|
2009-08-28 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adoptive cell therapy with young T cells
|
|
CN105153188B
(zh)
|
2009-10-22 |
2018-06-01 |
法博太科制药有限公司 |
抗纤维化剂的稠环类似物
|
|
MX2012004995A
(es)
|
2009-10-29 |
2012-10-03 |
Sirtris Pharmaceuticals Inc |
Piridinas biciclicas y analogos como moduladores de sirtuina.
|
|
US20120245171A1
(en)
|
2009-12-03 |
2012-09-27 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of pi3 kinases
|
|
JP2013512878A
(ja)
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
新規化合物
|
|
US20120238571A1
(en)
|
2009-12-03 |
2012-09-20 |
Glaxo Group Limited |
Indazole derivatives as pi 3-kinase
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
US20110142814A1
(en)
|
2009-12-16 |
2011-06-16 |
New York University |
Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive Immunotherapy
|
|
EP2542081A4
(en)
|
2010-03-01 |
2013-07-31 |
Gtx Inc |
COMPOSITIONS FOR CANCER TREATMENT
|
|
CA3253628A1
(en)
|
2010-03-05 |
2025-11-29 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
|
WO2011115892A1
(en)
|
2010-03-15 |
2011-09-22 |
Griffin Patrick R |
Modulators of the retinoic acid receptor-related orphan receptors
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201013443D0
(en)
|
2010-08-11 |
2010-09-22 |
Cytovac As |
Compositions and methods for producing dendritic cells
|
|
JP5876051B2
(ja)
|
2010-09-08 |
2016-03-02 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
インフルエンザウィルス感染の治療に使用するためのインダゾール誘導体
|
|
EP2614058B1
(en)
|
2010-09-08 |
2015-07-08 |
GlaxoSmithKline Intellectual Property Development Limited |
POLYMORPHS AND SALTS OF N-[5-[4-(5-{[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]METHYL}-& xA;1,3-OXAZOL-2-YL)-1H-INDAZOL-6-YL]-2-(METHYLOXY)-3-PYRIDINYL]METHANESULFONAMIDE
|
|
WO2012037108A1
(en)
|
2010-09-13 |
2012-03-22 |
Glaxosmithkline Llc |
Aminoquinoline derivatives as antiviral agents
|
|
US9512111B2
(en)
|
2010-11-08 |
2016-12-06 |
Lycera Corporation |
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
WO2012129394A2
(en)
|
2011-03-22 |
2012-09-27 |
Brigham And Women's Hospital, Inc. |
Methods and compositions for the treatment of cancer
|
|
WO2012127464A2
(en)
|
2011-03-23 |
2012-09-27 |
Gavish-Galilee Bio Applications Ltd |
Constitutively activated t cells for use in adoptive cell therapy
|
|
BR112013024395B1
(pt)
|
2011-03-23 |
2021-10-26 |
Fred Hutchinson Cancer Research Center |
Composições adotivas de imunoterapia celular e método para fabricação da dita composição
|
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
US9586928B2
(en)
|
2011-05-16 |
2017-03-07 |
The Scripps Research Institute |
Modulators of the nuclear hormone receptor ROR
|
|
CA2840272C
(en)
|
2011-06-24 |
2020-09-15 |
Glycoregimmune, Inc. |
Prevention and treatment of inflammatory conditions
|
|
RU2658013C2
(ru)
|
2011-09-19 |
2018-06-19 |
Этх Цюрих |
Модуляторы ror-гамма
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
WO2013135588A1
(en)
|
2012-03-16 |
2013-09-19 |
Covagen Ag |
Novel binding molecules with antitumoral activity
|
|
US9394315B2
(en)
|
2012-05-08 |
2016-07-19 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
|
|
WO2013167136A1
(en)
|
2012-05-08 |
2013-11-14 |
Herlev Hospital |
Improving adoptive cell therapy with interferon gamma
|
|
CN104284657A
(zh)
|
2012-05-08 |
2015-01-14 |
默沙东公司 |
用于抑制RORγ活性和治疗疾病的双环砜化合物
|
|
BR112014028017A2
(pt)
|
2012-05-08 |
2017-06-27 |
Lycera Corp |
composto, composição farmacêutica, método para tratar um distúrbio, método para reduzir a quantidade il-17 em um indivíduo e método para inibir a atividade de ror
|
|
EP2856142A1
(en)
|
2012-05-25 |
2015-04-08 |
Health Diagnostic Laboratory, Inc. |
Rapid and high-throughput analysis of sterols/stanols or derivatives thereof
|
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026329A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
|
WO2014028669A1
(en)
|
2012-08-15 |
2014-02-20 |
Biogen Idec Ma Inc. |
Novel compounds for modulation of ror-gamma activity
|
|
DK3489261T3
(da)
|
2012-08-24 |
2020-12-14 |
Univ California |
Antistoffer og vacciner til anvendelse ved behandling af ror1-cancere og hæmning af metastase
|
|
US20150329483A1
(en)
|
2012-12-17 |
2015-11-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and Pharmaceutical Compositions for the Treatment of X-Linked Charcot-Marie-Tooth
|
|
WO2014201378A1
(en)
|
2013-06-13 |
2014-12-18 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with extended-pk il -2 and adoptive cell therapy
|
|
US9809561B2
(en)
|
2013-12-20 |
2017-11-07 |
Merck Sharp & Dohme Corp. |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
|
|
US9663502B2
(en)
|
2013-12-20 |
2017-05-30 |
Lycera Corporation |
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
|
|
WO2015095792A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Carbamate benzoxaxine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease
|
|
AU2015222917A1
(en)
*
|
2014-02-27 |
2016-09-15 |
Lycera Corporation |
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
|
|
EP3209641A4
(en)
|
2014-05-05 |
2018-06-06 |
Lycera Corporation |
Benzenesulfonamido and related compounds for use as agonists of ror and the treatement of disease
|
|
EP3140291A4
(en)
|
2014-05-05 |
2018-01-10 |
Lycera Corporation |
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
|
|
CA2982847A1
(en)
*
|
2015-05-05 |
2016-11-10 |
Lycera Corporation |
Dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease
|